Skip to content

Peptide tracker

In clinical trials

Cagrilintide tracker

A private tracker for cagrilintide — the weekly amylin shot.

Cagrilintide is a weekly amylin analog studied for weight management, often paired with a GLP-1 (it's the "Cagri" half of CagriSema). Whether you're in a trial or tracking it yourself, Lirea keeps a private record of your dose and your trend — on your device, with no account.

No account required. Nothing leaves your phone.

Today

On your schedule

This week

Cagrilintide

on schedule

Logged

Weight check-in

trend
Log a dose

What you'll track

Made for how you actually take Cagrilintide.

A once-weekly subcutaneous injection.

A weekly shot, reminded

Pick your day; Lirea reminds you before it's due and logs it in one tap.

Track a long, slow climb

Cagrilintide is stepped up gradually over several weeks. Lirea shows which step you're on and lets you hold a level if you need to.

Often paired with a GLP-1

Many people run cagrilintide alongside semaglutide, tirzepatide, or retatrutide. Lirea keeps both on one private schedule.

Weight as the outcome that matters

Follow your weight as a trend over months, not a daily number.

Why Lirea

Your Cagrilintide data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log — and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Open by design

    A verifiable, auditable foundation — not just a promise.

Questions

Cagrilintide, tracked privately

Is cagrilintide a GLP-1?

No — it's an amylin analog, a different appetite mechanism. It's often combined with a GLP-1 (as in CagriSema) for a complementary effect. Lirea tracks it either on its own or alongside your GLP-1.

Is cagrilintide approved?

Standalone cagrilintide is not FDA-approved (the CagriSema combination is under FDA review). Lirea does not sell or supply it — it's a private tracker.

Can I track cagrilintide and my GLP-1 together?

Yes. Keep both on one private schedule, with the history encrypted on your device.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Many peptides are not approved by the FDA and are sold for research use only; Lirea neither sells nor supplies any compound. Always follow the guidance of a qualified healthcare provider.

Start privately

Your shot. Your data. Your device.

Track your weekly dose, your titration, and how you’re feeling — all on your device. No account required.

Coming soon to iOS and Android.